Cullinan Therapeutics, Inc. (CGEM) Revenue History
Cullinan Therapeutics, Inc. (CGEM) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2021-12-31 | $18.94M |
| 2022-12-31 | $100.00K |
| 2023-12-31 | $500.00K |
| 2024-12-31 | N/A |
| 2025-12-31 | N/A |
How CGEM compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | $500.00K |
| MNOV | MediciNova Inc. | $409.66K |
| PLSE | Pulse Biosciences Inc | $350.00K |
| BNTC | Benitec Biopharma Inc. | $75.00K |
| INO | Inovio Pharmaceuticals Inc. | $65.34K |
These are five companies in the same sector as CGEM with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Cullinan Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("CGEM", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CGEM | $21.68 | +1.40% | 0.76M |
| 3 | ||||
| 4 | ||||
| 5 |